Assignee
OXFORD BIOMEDICA LTD
GB·51 granted patents·39 pending applications·1,264 citations·filing 1995–2024
Top patents by PatentIndex Score
90 records- 0198US7351585B2Retroviral vectorOXFORD BIOMEDICA LTD·Filed 2003·Granted Apr 1, 2008·153 cites·14 claims
- 0297US7303910B2Retroviral vectors comprising a functional splice donor site and a functional splice acceptor siteOXFORD BIOMEDICA LTD·Filed 2004·Granted Dec 4, 2007·137 cites·6 claims
- 0397US7056699B2Lentiviral LTR-deleted vectorOXFORD BIOMEDICA LTD·Filed 2005·Granted Jun 6, 2006·46 cites·9 claims
- 0497US6924123B2Lentiviral LTR-deleted vectorOXFORD BIOMEDICA LTD·Filed 2002·Granted Aug 2, 2005·64 cites·6 claims
- 0596US7585676B2Retroviral vectorOXFORD BIOMEDICA LTD·Filed 2008·Granted Sep 8, 2009·37 cites·18 claims
- 0693US7514546B2AntibodiesOXFORD BIOMEDICA LTD·Filed 2006·Granted Apr 7, 2009·13 cites·25 claims
- 0793US7198784B2Retroviral vectorsOXFORD BIOMEDICA LTD·Filed 2003·Granted Apr 3, 2007·43 cites·19 claims
- 0893US7070994B2Packaging cellsOXFORD BIOMEDICA LTD·Filed 2002·Granted Jul 4, 2006·46 cites·5 claims
- 0993US6312682B1Retroviral vectorsOXFORD BIOMEDICA LTD·Filed 1998·Granted Nov 6, 2001·115 cites·71 claims
- 1092US6783981B1Anti-viral vectorsOXFORD BIOMEDICA LTD·Filed 2000·Granted Aug 31, 2004·38 cites·22 claims
- 1191US7419829B2Vector systemOXFORD BIOMEDICA LTD·Filed 2004·Granted Sep 2, 2008·60 cites·31 claims
- 1291US7074909B2AntibodiesOXFORD BIOMEDICA LTD·Filed 2001·Granted Jul 11, 2006·27 cites·13 claims
- 1389US6669936B2Retroviral vectorsOXFORD BIOMEDICA LTD·Filed 2001·Granted Dec 30, 2003·34 cites·75 claims
- 1488US7148035B1PolypeptideOXFORD BIOMEDICA LTD·Filed 2000·Granted Dec 12, 2006·12 cites·12 claims
- 1588US6541248B1Anti-viral vectorsOXFORD BIOMEDICA LTD·Filed 2000·Granted Apr 1, 2003·19 cites·10 claims
- 1688US6312683B1Equine infectious anemia virus vectorsOXFORD BIOMEDICA LTD·Filed 1999·Granted Nov 6, 2001·73 cites·64 claims
- 1786US9339512B2Method for vector deliveryOXFORD BIOMEDICA LTD·Filed 2013·Granted May 17, 2016·7 cites·13 claims
- 1886US7666669B2PolypeptideOXFORD BIOMEDICA LTD·Filed 2006·Granted Feb 23, 2010·2 cites·11 claims
- 1986US7531648B2Vector encoding an antibody that binds 5T4 antigenOXFORD BIOMEDICA LTD·Filed 2002·Granted May 12, 2009·8 cites·13 claims
- 2086US6800281B2Lentiviral-mediated growth factor gene therapy for neurodegenerative diseasesOXFORD BIOMEDICA LTD·Filed 2001·Granted Oct 5, 2004·17 cites·15 claims
- 2184US7718627B2VectorOXFORD BIOMEDICA LTD·Filed 2006·Granted May 18, 2010·4 cites·24 claims
- 2284US6852703B1Tumor targeted vectorOXFORD BIOMEDICA LTD·Filed 1998·Granted Feb 8, 2005·39 cites·31 claims
- 2383US7601698B2PolypeptideOXFORD BIOMEDICA LTD·Filed 2005·Granted Oct 13, 2009·1 cites·9 claims
- 2483US5942434ANucleic acid constructs comprising hypoxia response elementsOXFORD BIOMEDICA LTD·Filed 1995·Granted Aug 24, 1999·57 cites·22 claims
- 2582US7910109B2MHC class II epitopes of 5T4 antigenOXFORD BIOMEDICA LTD·Filed 2003·Granted Mar 22, 2011·8 cites·5 claims
- 2681US6096538ARetroviral vectorsOXFORD BIOMEDICA LTD·Filed 1996·Granted Aug 1, 2000·52 cites·36 claims
- 2780US7615612B2PolypeptideOXFORD BIOMEDICA LTD·Filed 2007·Granted Nov 10, 2009·2 cites·16 claims
- 2880US2025115880A1Viral vector production systemOXFORD BIOMEDICA LTD·Filed 2024·Application pending·0 cites
- 2978US10400252B2Catecholamine enzyme fusionsOXFORD BIOMEDICA LTD·Filed 2012·Granted Sep 3, 2019·3 cites·12 claims
- 3078US7790419B2Antiviral vectorsOXFORD BIOMEDICA LTD·Filed 2003·Granted Sep 7, 2010·4 cites·42 claims
- 3177US6235522B1Lentiviral vectorsOXFORD BIOMEDICA LTD·Filed 1997·Granted May 22, 2001·40 cites·15 claims
- 3276US10544429B2Viral vector production systemOXFORD BIOMEDICA LTD·Filed 2014·Granted Jan 28, 2020·2 cites·8 claims
- 3376US7888115B2MHC class I peptide epitopes from the human 5T4 tumor-associated antigenOXFORD BIOMEDICA LTD·Filed 2009·Granted Feb 15, 2011·1 cites·2 claims
- 3475US7659383B2Feline 5T4 antigenOXFORD BIOMEDICA LTD·Filed 2008·Granted Feb 9, 2010·2 cites·6 claims
- 3575US7541044B2Administration of 5T4 antigen and immune response of cells expressing 5T4 and CEA antigensOXFORD BIOMEDICA LTD·Filed 2006·Granted Jun 2, 2009·2 cites·16 claims
- 3675US7276488B2Vector systemOXFORD BIOMEDICA LTD·Filed 2002·Granted Oct 2, 2007·2 cites·18 claims
- 3774US12312592B2Retroviral vectorOXFORD BIOMEDICA LTD·Filed 2023·Granted May 27, 2025·0 cites·12 claims
- 3873US2010040539A1Vector SystemOXFORD BIOMEDICA LTD·Filed 2008·Application pending·0 cites
- 3971US12054735B2Viral vector production systemOXFORD BIOMEDICA LTD·Filed 2019·Granted Aug 6, 2024·0 cites·13 claims
- 4071US7635687B2Vector systemOXFORD BIOMEDICA LTD·Filed 2002·Granted Dec 22, 2009·2 cites·7 claims
- 4169US2009017532A1VectorOXFORD BIOMEDICA LTD·Filed 2008·Application pending·0 cites
- 4267US7575916B2Nucleic acid molecule encoding a MHC class I peptide epitope from the human 5T4 tumor-associated antigen and vector comprising the nucleic acid moleculeOXFORD BIOMEDICA LTD·Filed 2003·Granted Aug 18, 2009·3 cites·2 claims
- 4367US6818209B1Retroviral delivery systemOXFORD BIOMEDICA LTD·Filed 1999·Granted Nov 16, 2004·21 cites·21 claims
- 4467US2005032216A1VectorOXFORD BIOMEDICA LTD·Filed 2004·Application pending·0 cites
- 4566US6808922B1Retroviral vectors comprising a functional splice donor site and a functional splice acceptor siteOXFORD BIOMEDICA LTD·Filed 1998·Granted Oct 26, 2004·14 cites·41 claims
- 4665US2025034589A1Lentiviral VectorsOXFORD BIOMEDICA LTD·Filed 2022·Application pending·0 cites
- 4765US2023084645A1MethodOXFORD BIOMEDICA LTD·Filed 2022·Application pending·0 cites
- 4864US11427645B25T4-targeting agents and methodsOXFORD BIOMEDICA LTD·Filed 2018·Granted Aug 30, 2022·0 cites·34 claims
- 4964US6168916B1Host adaptation of retroviral vectorsOXFORD BIOMEDICA LTD·Filed 1996·Granted Jan 2, 2001·23 cites·20 claims
- 5064US2010310584A1AntigenOXFORD BIOMEDICA LTD·Filed 2009·Application pending·0 cites
Showing the top 50 of 90 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when OXFORD BIOMEDICA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →